These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11071558)

  • 1. Prolongation of heterotopic heart allograft survival by portal venous injection of alloantigen: the role of hepatic nonparenchymal cells.
    Smith RM; Chen Y; McKenna GJ; Ong C; Zhang R; Chung SW
    J Invest Surg; 2000; 13(5):241-6. PubMed ID: 11071558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver nonparenchymal cells involved in hyporesponsiveness induced by portal vein injection of alloantigen.
    Chen Y; McKenna GJ; Ong C; Mui AL; Chung SW
    Immunol Lett; 2002 Apr; 81(1):1-11. PubMed ID: 11841840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.
    Chung SW; Gorczynski RM; Dziadkowiec I; Levy GA
    Immunology; 1995 Aug; 85(4):582-90. PubMed ID: 7558153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of specific tolerance by hepatic double-negative CD4-8- alpha beta T cells of mice immunized with allogeneic cells via the portal vein in vivo [corrected].
    Koyamada N; Ohteki T; Abo T; Fukumori T; Ohkouchi N; Satomi S; Taguchi Y; Kusumi A; Mori S; Kumagai K
    Cell Immunol; 1993 Jun; 149(1):107-16. PubMed ID: 7685658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune hyporesponsiveness after portal vein immunization with ovalbumin.
    Chen Y; Ong CR; McKenna GJ; Mui AL; Smith RM; Chung SW
    Surgery; 2001 Jan; 129(1):66-75. PubMed ID: 11150035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes.
    Tokita D; Ohdan H; Onoe T; Hara H; Tanaka Y; Asahara T
    Transpl Int; 2005 Feb; 18(2):237-45. PubMed ID: 15691278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of alloantigen-specific CD4+ T regulatory Type 1 cells by alloantigen immunization and ultraviolet-B irradiation: a pilot study in murine transplantation models with skin and cardiac allografts.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Ann Transplant; 2014 Oct; 19():519-36. PubMed ID: 25322948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
    Yu S; Nakafusa Y; Flye MW
    Transplantation; 1997 Dec; 64(12):1684-8. PubMed ID: 9422402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice.
    Akiyama Y; Shirasugi N; Uchida N; Matsumoto K; Kitajima M; Bashuda H; Yagita H; Okumura K; Aramaki O; Niimi M
    Transplantation; 2002 Sep; 74(5):732-8. PubMed ID: 12352894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
    Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival.
    Zhang M; Wang Q; Liu Y; Sun Y; Ding G; Fu Z; Min Z; Zhu Y; Cao X
    J Mol Med (Berl); 2004 Apr; 82(4):240-9. PubMed ID: 15168681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.